Biotechnology is witnessing a surge of innovation in phage discovery, with new functional screening platforms reshaping drug development and antibody engineering. Recent advancements highlight how phage display is evolving from a binding-focused tool into a powerful engine for therapeutic breakthroughs.   Functional Target Screening: Moving Beyond Binding Traditional phage display often...

In recent years, biologics have emerged as one of the most promising frontiers in medicine. From monoclonal antibodies to engineered proteins, these therapies are reshaping how scientists approach cancer, autoimmune disorders, and infectious diseases. Yet, before any candidate reaches clinical trials, researchers must navigate a series of hurdles in the preclinical stage—manufacturing...

Recent years have witnessed remarkable advancements in neuroscience, largely propelled by innovative technologies and interdisciplinary research. Among these, induced pluripotent stem cells (iPSCs) have emerged as a transformative tool, enabling scientists to explore the complexities of the human nervous system like never before. As the global scientific community grapples with neurological...

Neuroscience research advances the understanding and development of new treatments for neurological disorders. The contributions of neuros services and products have played a crucial role in facilitating this rapid advancement. Biotechnology companies play a pivotal role in providing cutting-edge neural products that are instrumental in enabling groundbreaking discoveries and advancements...

The complement system, a crucial component of innate immunity, plays a multifaceted role in host defense, inflammation, and immune regulation. As research into complement-targeted therapies accelerates, the need for reliable and nuanced testing methods has become increasingly apparent. A range of specialized assays now enables scientists to evaluate complement activity with precision,...

In the dynamic landscape of regenerative medicine, induced pluripotent stem cells (iPSCs) have revolutionized the way researchers approach cell-based therapies and disease modeling. Among the most promising applications is the generation of neural crest cells, Schwann cells, and astrocytes—three critical cell types that play essential roles in the development and maintenance of the...

Creative Biolabs is proud to announce its upcoming webinar, "Programming Cytokine Sensing: A Blueprint for Durable CAR-T", scheduled for December 11, 2025, at 10:00 AM EST. This event will spotlight cutting-edge strategies to overcome one of the most pressing challenges in CAR-T therapy for solid tumors: the dual role of interferon-gamma (IFNγ).   CAR-T therapy has revolutionized the...

The human brain is a marvel of complexity, but studying it has always been a challenge. Traditional models—animal testing, 2D cell cultures, even postmortem tissue—often fall short in replicating the dynamic environment of a living brain. Enter brain organoids: tiny, lab-grown structures that mimic the architecture and function of human brain regions. These 3D models are opening new...

Chimeric Antigen Receptor T-cell (CAR-T) therapy has revolutionized the treatment landscape for hematologic malignancies, offering targeted, durable responses where conventional therapies often fall short. But what if this cellular precision could be redirected beyond cancer—to chronic, non-oncological diseases like hemophilia or transplant rejection?   Recent advances suggest that...

Gene therapy has entered a new era—one defined not just by bold concepts, but by molecular finesse. At the heart of this transformation are oligonucleotides: short strands of nucleic acids that can silence, edit, or regulate genes with remarkable specificity. But their journey from concept to clinic is anything but straightforward.   The Challenge: Biological Barriers Unmodified...